Trouble with IMI, BH, is that they have 1.2 billion shares on issue and a product that is not disposable. Once you have the product, you have it, unlike SBN where you need a new one every time you test. The costs and the growth potential just don't stack up. It is only my opinion, without a lot of in depth research, but I only do one share at a time.
Trouble with IMI, BH, is that they have 1.2 billion shares on...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)